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Urea derivativesAbstract A quantitative structure–activity relationship (QSAR) was performed to analyze antima-
larial activities of 68 urea derivatives using multiple linear regressions (MLR). QSAR analyses were
performed on the available 68 IC50 oral data based on theoretical molecular descriptors. A suitable
set of molecular d
escriptors were calculated to represent the molecular structures of compounds, such as constitu-
tional, topological, geometrical, electrostatic and quantum-chemical descriptors. The important
descriptors were selected with the aid of the genetic algorithm (GA) method. The obtained model
was validated using leave-one-out (LOO) cross-validation; external test set and Y-randomization
test. The root mean square errors (RMSE) of the training set, and the test set for GA–MLR model
were calculated to be 0.314 and 0.486, the square of correlation coefﬁcients (R2) were obtained 0.801
and 0.803, respectively. Results showed that the predictive ability of the model was satisfactory, and
it can be used for designing similar group of antimalarial compounds.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Malaria is one of the most prevalent diseases of our planet,
which claims millions of lives annually. The health problem
caused by malaria, one of the most lethal of the parasitic
diseases, is now compounded due to the emergence of strains
of plasmodium, which show resistance to the known chemo-
therapeutic agents. The paucity of new affordable drugs has
not only complicated the clinical management of malaria in
endemic areas, but has also resulted in an increase in the mor-
tality rate (Rastelli et al., 2003). This situation underscores
QSAR modeling of antimalarial activity of urea derivatives using genetic algorithm–multiple linear regressions 283needs for urgent discovery of new antimalarial agents. The
artemisinin and its derivatives or their combinations have
now replaced the chloroquine (CQ) and other quinoline anti-
malarials, especially in the endemic areas. However lower
abundance and high cost of artemisinin and related products
motivate the medicinal chemists to search for new chemical
pharmacophores which may prove effective as antimalarial.
Although there are several experimental methods available
for screening the estrogenic activity of chemicals (e.g.,
in vivo and in vitro assay tests), and these all have also been
carried out using receptors and other biological materials of
human, rat, mouse, and calf origin at least (Hill, 1972), they
are costly, time-consuming, and can potentially produce toxic
side products from the experimental methods used today. The
efﬁcient way to obtain a complete set of the data, without
necessity of performing expensive laboratory experiments is
the application of the quantitative structure–activity relation-
ship (QSAR) techniques. The QSAR is one of the most impor-
tant areas in chemometrics, and is a valuable tool that is used
extensively in drug design and medicinal chemistry (Hansch
et al., 1990; Manly et al., 2001; Pourbasheer et al., 2010,
2011). Chemical and biological effects are related closely to
molecular physico-chemical properties, which can be calcu-
lated or predicted by their structure using various kinds of
methods (Burger and Abraham, 2003). Once a reliable QSAR
model is established, we can predict the activities of molecules,
and know which structural features play a signiﬁcant role in
the biological process. The advances in QSAR studies have
widened the scope of rational drug design as well as the search
for the mechanisms of drug actions. Many different methodol-
ogies, such as multiple linear regression (MLR), partial least
squares (PLS), heuristic method (HM), and different types
of artiﬁcial neural networks (ANN), can be applied for QSAR
development. Genetic algorithm (GA) has gained great popu-
larity in QSAR research. The GA–MLR method, developed
by Rogers and Hopﬁnger (Rogers and Hopﬁnger, 1994), is
employed in a statistical analysis to select the relevant descrip-
tors and to generate different QSAR models. Sensitivity anal-
ysis of QSAR models is then performed, and the best model
developed can be used for predicting test set molecules that
were not included in the training set molecules. Randomiza-
tion tests performed on the model at various intervals of con-
ﬁdence levels ensure its proper validation. The main aim of the
present work is to establish a new QSAR model for predicting
antimalarial activity of 68 urea derivatives using GA–MLR
technique.2. Data set and methods
2.1. Data set
In this study, a data set of 68 urea derivatives was col-
lected from the literature (Madapa et al., 2009a,b; Mishra
et al., 2009). The chemical structures and antimalarial
activity (IC50) of these 68 molecules are presented in
Table 1. The IC50 values were converted into its logarithmic
scale pIC50 = log (IC50), to reduce the skewness of the
data set, which was then used for subsequent QSAR anal-
ysis as the response variable. It is essential to assess the
predictive power of QSAR models by using a test set of
molecules according to the following criteria: (1) the anti-malarial activity values of the test set should span the
training set several times; (2) the biological assay methods
for both the training set and test set should be the same or
comparable; (3) the test set should represent a balanced
number of both active and inactive molecules for uniform
sampling of the data set. The remaining molecules are
taken as the training set in order to create an efﬁcient
QSAR model.
2.2. Descriptor calculation
All of the molecules were drawn into the HyperChem (Version
7.0 Hypercube, Alberta, Canada) software and pre-optimized
using the MM+molecular mechanics force ﬁeld. Then a more
precise optimization was performed with the semi-empirical
AM1 method in MOPAC (Stewart, 1989). Descriptors were
calculated using the CODESSA (Katritzky et al., 1994) and
DRAGON software package (Todeschini et al., 2003) which
include: constitutional, topological, geometrical, electrostatic,
charged partial surface area, quantum-chemical, molecular
orbital and thermodynamic descriptors. Before commencing
with the development of the QSAR model, the correlation ma-
trix of about 457 descriptors was calculated and highly corre-
lated descriptors, with correlation values above 0.9, were
removed. Furthermore, descriptors with constant values as
well as those with poor correlation the antimalarial activity
were discarded; some descriptors having zero value were also
discarded. Finally, remained descriptors were considered for
statistical ﬁtting using the GA–MLR method.
2.3. Genetic algorithm for descriptor selection
Genetic algorithms (GAs) are governed by biological evolution
rules (Hunger and Huttner, 1999; Aires-de-Sousa et al., 2002;
Ahmad and Gromiha, 2003). The GAs, which are based on
the principles of Darwinian evolution, have emerged as robust
optimization and search methods (Holland, 1975). In a GA
feature selection procedure, potential solutions for the prob-
lem being studied are subsets of molecular descriptors. They
are represented as data structures called chromosomes, which
are binary strings of length N (the total number of available
features), with a zero or one in position i indicating the absence
or presence of feature i in the set. The initial population of
chromosomes is usually generated randomly. After that, GA
runs in cycles. The ﬁtness of each chromosome is evaluated
by the ﬁtness function. The ﬁtness function used here was
the leave-one-out, cross-validated correlation coefﬁcient
(Q2LOO). New chromosomes are then created by genetic opera-
tors such as crossovers and mutations. Crossover occurs when
two parent chromosomes exchange parts of their correspond-
ing elements. Mutations induce sporadic alterations of ran-
domly selected chromosome elements. In each cycle, a new
chromosome (feature set) is produced either by mutation or
crossover on the selected parents, and it is compared with
the worst member of the existing population. If the new one
is better, it becomes a member of the population, and the ori-
ginal worst one is discarded; if not, the new one is discarded,
and GA goes into next generation with the population un-
changed. The genetic algorithm cycle is repeated until a satis-
factory descriptor set is found or a pre-set limit of generation is
reached. The GA program was written in Matlab 6.5.
Table 1 Structure, experimental, and predicted activity of urea derivatives.
No. General structure R1 R2 Exp. Pred. Ref.
1
HN
N
N
H
N
H
N
R2
S
R1
3-CF3 Ph 3.00 2.669 b
2 3-CF3 3-CN-C6H4 2.65 1.902 b
3 3-CF3 4-Br-C6H4 1.59 2.158 b
4 3,4-(OMe)2 Ph 2.48 2.744 b
5 3,4-(OMe)2 3-F-C6H4 2.59 2.513 b
6 3,4-(OMe)2 4-Br-C6H4 2.83 2.913 b
7 3,4-(OMe)2 1-Naphtyl 2.32 2.167 b
8a 4-OMe Ph 2.38 2.653 b
9 4-OMe 3-F-C6H4 1.73 2.145 b
10 4-OMe 4-Br-C6H4 1.70 1.611 b
11 H 3-F-C6H4 2.90 2.965 b
12a H 3-Cl-C6H4 2.91 2.619 b
13 3-OMe Ph 2.41 2.183 b
14a 3-OMe 3-F-C6H4 1.43 1.853 b
15 3-OMe 3-CN-C6H4 1.32 1.331 b
16 3-OMe 3-Cl-C6H4 1.06 1.642 b
17 3-OMe 4-Br-C6H4 2.02 1.523 b
18a 3-Cl 4-Br-C6H4 2.72 2.178 b
19a
H
N
H
N
N
HN
O
R2
R1 O
Ph 3,4-Cl2 1.04 1.946 c
20 Ph 4-Cl-3-CF3 1.29 1.507 c
21a 2-Cl-C6H4 3-Cl 2.34 2.163 c
22 2-Cl-C6H4 3-Cl-4-Me 1.45 2.095 c
23 2-Cl-C6H4 3-CN 1.65 0.972 c
24 2-Cl-C6H4 3,4-Cl2 2.29 2.056 c
25 2-Cl-C6H4 3,5-Cl2 1.34 1.492 c
26 2-Cl-C6H4 4-Cl-3-CF3 1.55 1.214 c
27 3-Cl-C6H4 4-Cl 1.16 1.396 c
28 3-Cl-C6H4 3-CF3 1.00 1.157 c
29 3-Cl-C6H4 3-Cl-4-Me 1.53 2.019 c
30 3-Cl-C6H4 3,4-Cl2 2.34 1.962 c
31a 3-Cl-C6H4 3-Cl-4-F 1.83 1.907 c
32 2-furyl 4-Cl 1.14 1.437 c
33 2-furyl 3-Br 1.76 1.758 c
34 2-furyl 3-CN 0.40 0.188 c
35 2-furyl 3-Cl-4-Me 2.13 1.848 c
36 2-furyl 4-Cl-3-CF3 1.00 0.921 c
37a
N N MeH2C
4-Cl 0.70 1.256 c
2
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38
N N MeH2C
3-Cl 1.11 1.355 c
39
N N MeH2C
3-CF3 0.10 0.341 c
40
N N MeH2C
4-COMe 1.15 1.658 c
41
N N MeH2C
3-COMe 2.17 1.706 c
42
N N MeH2C
3-Cl-4-Me 0.52 0.794 c
43a
N N MeH2C
3,4-Cl2 0.34 0.377 c
44a
N N MeH2C
3,5-Cl2 0.40 0.444 c
45a
N N EtH2C
4-Cl-3-CF3 1.26 1.371 c
46
N N EtH2C
3-CF3 1.45 1.206 c
47
N N EtH2C
3-Cl-4-Me 0.54 0.199 c
(continued on next page)
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Table 1 (continued)
No. General structure R1 R2 Exp. Pred. Ref.
48
NH2C
4-Cl 1.36 1.466 c
49
NH2C
3-3CF3 1.53 1.411 c
50
NH2C
3-Cl-4-Me 2.56 2.106 c
51
NH2C
3,4-Cl2 1.88 1.916 c
52
NH2C
3,5-Cl2 1.46 1.859 c
53a – 4-Cl-3-CF3 1.55 1.559 c
54 – – 0.3 0.386 c
55
HN
N
N
H
N
H
N
O
R1
R2
H 4-Br 2.24 2.095 d
56a 3-F 3-Cl-4-Me 2.17 1.577 d
57 3-F 3,4-Cl2 1.39 1.761 d
58 3-CF3 4-Cl 1.83 1.746 d
59 3-CF3 3,4-Cl2 1.11 0.757 d
60a 3-CF3 4-Cl-3-CF3 0.36 1.012 d
61 3-OMe 4-Cl 2.20 2.143 d
62 4-OMe 4-Cl 1.97 1.581 d
63 4-OMe 3-Cl-4-Me 1.70 1.939 d
64 4-Me 4-Cl 1.89 1.775 d
65 3,4-(OMe)2 3-Cl-4-Me 1.35 1.536 d
66 3,4-(OMe)2 3,4-Cl2 1.91 1.632 d
67 3,4-(OMe)2 3,4-Cl2 1.92 1.690 d
68 3,4-(OMe)2 4-Cl-3-CF3 1.26 1.357 d
a Test set.
b Mishra et al. (2009).
c Madapa et al. (2009a).
d Madapa et al. (2009b).
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Figure 2 The residuals vs. experimental pIC50 values for the
training and test sets.
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A QSAR analysis was performed to explore the structure–
activity relationship of different 68 urea derivatives acting as
antimalarial. In a QSAR study, generally, the quality of a
model is expressed by its ﬁtting and prediction ability. In order
to build and test model, a data set of 68 compounds was sep-
arated into a training set of 54 compounds, which was used to
build model and a test set of 14 compounds, which was applied
to evaluate the built model. The GA–MLR analysis led to the
derivation of one model, with eight descriptors. With the se-
lected descriptors, we have built the linear model using the
training set data, and obtained the following equation:
pIC50 ¼ 14:141 7:372 ðXY ShadowÞ  2:072 ðHOMO
 1Þ  98:437 ðMERICÞ  5:004 ðESPMNACHÞ
 0:062 ðTðO::OÞÞ þ 5:472 ðMATS2vÞ
þ 12:585 ðHATS4uÞ  0:837 ðMlogPÞ
Ntrain ¼ 54;R2train ¼ 0:801;Ftrain ¼ 22:638;Q2LOO ¼ 0:722;Q2LGO ¼ 0:748;
Ntest ¼ 14;R2test ¼ 0:803;RMSEtrain ¼ 0:314;RMSEtest ¼ 0:486
ð1Þ
In this equation, N is the number of compounds, R2 is the
squared correlation coefﬁcient, Q2LOO, and Q
2
LGO are the
squared cross-validation coefﬁcients for leave one out and
leave group out respectively, F is the Fisher F statistic, and
RMSE is the root mean square error. The built model was
used to predict the test set data, and the prediction results
are given in Table 1. The predicted values for pIC50 for the
compounds in the training and test sets using equation 1 were
plotted against the experimental pIC50 values in Fig. 1. As can
be seen from Table 1 and Fig. 1, the calculated values for the
pIC50 are in good agreement with those of the experimental
values. Also, the plot of the residual for the predicted values
of pIC50 for both the training and test sets against the experi-
mental pIC50 values are shown in Fig. 2. As can be seen the
model did not show any proportional and systematic error, be-
cause the propagation of the residuals on both sides of zero is
random.-3.5
-2.5
-1.5
-0.5
0.5
-3.5 -2.5 -1.5 -0.5 0.5
Pr
ed
ic
te
d 
(pI
C 5
0)
Experimental (pIC50)
Training
Test
Figure 1 The calculated pIC50 against the experimental values
for the training and test sets.3.1. QSAR model validation
The real usefulness of QSAR models is not just their ability to
reproduce known data, veriﬁed by their ﬁtting power (R2), but
mainly is their potential for predictive application. For this
reason, the internal consistency of the training set was con-
ﬁrmed by using leave-one-out (LOO) cross-validation method
to ensure the robustness of the model. The high calculated
Q2LOO value, 0.722 suggests a good internal validation. A sec-
ond validation method was also developed on the basis of a
leave-group-out (LGO) internal cross-validation method. In
this case, a group of compounds including 20% of the training
data set were left out and predicted later by the model obtained
with the remaining 80% of the data. This process was repeated
100 times for each one of the 100 unique subsets selected at
random. The overall mean for this process (20% full-leave-
out cross-validation), Q2LOO ¼ 0:748 indicates the robustness
and stability of the constructed model.
The leverage values can be calculated for every compound
and plotted vs. standardized residuals, and it allows a graphi-
cal detection of both the outliers and the inﬂuential chemicals
in a model. Fig. 3, shows the Williams plot, the applicability
domain is established inside a squared area within ±3 bound-4
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Figure 3 The Williams plot, the plot of the standardized
residuals versus the leverage value.
Table 2 Speciﬁcation of entered descriptors in genetic algorithm multiple regression model.
Descriptors Deﬁnition MEa VIFb
XY shadow XY shadow/XY rectangle 0.343 1.680
HOMO-1 Energy of the molecular orbital below HOMO 1.511 3.321
MERIC Max electroph. react. index for a C atom 0.195 2.797
ESP-MNACH ESP-min net atomic charge for a H atom 0.039 1.936
T(O  O) Sum of topological distances between oxygen atoms 0.044 3.690
MATS2v Moran autocorrelation – lag 2/weighted by atomic van der Waals volumes 0.003 1.893
HATS4u Leverage-weighted autocorrelation of lag 4/unweighted 0.318 2.229
M logP Moriguchi octanol–water partition coeﬃcient 0.205 3.143
a Mean effect.
b Variation inﬂation factor.
Table 3 R2train and Q
2
LOO values after several Y-randomization
tests.
Iteration R2train Q
2
LOO
1 0.126 0.079
2 0.011 0.197
3 0.003 0.202
4 0.250 0.049
5 0.037 0.279
6 0.001 0.148
7 0.046 0.093
8 0.016 0.225
9 0.001 0.160
10 0.015 0.108
288 A. Beheshti et al.for residuals and a leverage threshold h* (h* = 3p0/n, where p0
is the number of model parameters and n is the number of
compounds) (Netzeva et al., 2005; OECD, 2007). It demon-
strates that all the compounds of the training set and test set
are inside of this square area. From Fig. 3, it is obvious that
there are no outlier compounds with standard residuals >3d
for both the training and test sets. Furthermore, all the chem-
icals have a leverage lower than the warning h* value of 0.50.
The multi-collinearity between the above eight descriptors
was detected by calculating their variation inﬂation factors
(VIF), which can be calculated as follows:
VIF ¼ 1
1 R2 ð2Þ
where R2 is the correlation coefﬁcient of the multiple regres-
sion between the variables within the model. If VIF equals to
1, then no inter-correlation exists for each variable; if VIF falls
into the range of 1–5, the related model is acceptable; and if
VIF is larger than 10, the related model is unstable and a re-
check is necessary (Shapiro and Guggenheim, 1998; Jaiswal
et al., 2004). The corresponding VIF values of the eight
descriptors are presented in Table 2. As can be seen from this
table, all the variables have VIF values of less than ﬁve, indi-
cating that the obtained model has statistical signiﬁcance,
and the descriptors were found to be reasonably orthogonal.
In order to assess the robustness of the model, the Y-ran-
domization test was applied in this study (Tropsha et al.,
2003). Y-randomization test conﬁrms whether the model is ob-
tained by chance correlation, and is a true structure–activity
relationship to validate the adequacy of the training set mole-
cules. The steps followed during the randomization test are (I)
repeatedly scrambling the activity data in the training set mol-
ecules, (II) using the randomized data to generate QSAR equa-
tions, and (III) comparing the resulting scores with the score of
the original QSAR equation generated with non-randomized
data. If the activity prediction of the random model is compa-
rable to that of the original equation, the set of observations is
not sufﬁcient to support the model. The new QSAR models
(after several repetitions) would be expected to have low R2
and Q2LOO values (Table 3). If the opposite happens, then an
acceptable QSAR model cannot be obtained for the speciﬁc
modeling method and data. The results of Table 3 indicate that
an acceptable model is obtained by GA–MLR method, and
the model developed is statistically signiﬁcant and robust.3.2. Interpretation of descriptors
By interpreting the descriptors contained in the QSAR model,
it is possible to gain some insights into factors, which are re-
lated to the antimalarial activity. For this reason, an accept-
able interpretation of the selected descriptors is provided
below. The brief descriptions of descriptors are shown in Ta-
ble 2. To examine the relative importance as well as the contri-
bution of each descriptor in the model, the value of the mean
effect (MF) was calculated for each descriptor (Pourbasheer
et al., 2009; Riahi et al., 2009). The MF value indicates the rel-
ative importance of a descriptor, compared with the other
descriptors in the model. Its sign indicates the variation direc-
tion in the values of the activities as a result of the increase (or
reduction) of the descriptor values. The mean effect values are
given in Table 2.
XY shadow/XY rectangle is a geometrical descriptor char-
acterizing the shape and extent of the molecule in terms of its
3D coordinates. This descriptor represents a two-dimensional
projection on the X–Y plane of a three-dimensional molecule
(Rohrbaugh and Jurs, 1987). Orientation of a molecule along
the axes of inertia (X-coordinate) casts a shadow of the mole-
cule projected on the X–Y plane. Normalized shadows are cal-
culated by XY shadow/XY rectangle. A negative mean effect
of this descriptor illustrates that the activity increases with
decreasing the value of XY shadow, which means that a smal-
ler area of molecular shadow in the enclosing rectangle will
beneﬁt the activity.
QSAR modeling of antimalarial activity of urea derivatives using genetic algorithm–multiple linear regressions 289The highest occupied molecular orbital (HOMO) energy is
obtained from molecular orbital calculations and represents
the electron accepting capability of the molecule. In this case,
the HOMO-1 represents the energy of the molecular orbital be-
low HOMO. The energies of the frontier orbitals are important
properties in several chemicals and pharmacological processes,
and the reason for this is the fact that these properties give
information on the electron-donating and electron-accepting
character of a compound, i.e., on the formation of a charge
transfer complex. The HOMO-1 mean effect has a positive
sign. This sign suggests that the antimalarial activity is directly
related to this descriptor.
Maximum electrophilic reactivity index for a C atom
(MERIC), is one of the quantum chemical descriptors, which
has been appeared in the model. This is a reactivity indices
descriptor which estimates the relative reactivity of the atoms
within the molecule for a given series of compounds and is re-
lated to the activation energy of the corresponding chemical
reaction. Since most atoms are the C atoms in the present
investigation, this descriptor can be responsible for the
reactivity of compounds. As it can be apparent to Table 2,
mean effect of MERIC has the negative sign. This sign sug-
gests that the antimalarial activity is inversely related to this
descriptor.
Electrostatic potential-minimum net atomic charge for an
H atom (ESP-MNACH) is an electrostatic potential-based
charge calculated descriptor. This descriptor reﬂects the charge
distribution in the hydrogen atoms within the molecule and
characterizes the intermolecular electrostatic interactions.
Negative mean effect for this descriptor indicates that an in-
crease in the activity is observed as a decrease in the minimum
net atomic charge on H atom.
The next descriptor is T(O  O), which is one of the topo-
logical descriptors. The T(O  O) is the summation of topolog-
ical distances between oxygen atoms within the molecule
(Todeschini and Consonni, 2000). A negative mean effect va-
lue indicates that increasing the distance between the two oxy-
gen atoms within a molecule increases the antimalarial activity.
MATS2v (Moran autocorrelation – lag 2/weighted by
atomic van der Waals volumes) belongs to the 2D autocorrela-
tion descriptors. The 2D autocorrelation descriptors have been
successfully employed by Fernandez et al. (Fernandez et al.,
2005; Caballero et al., 2007). In these descriptors, the molecule
atoms represent a set of discrete points in space, and the atom-
ic property and function are evaluated at those points. The
physico-chemical property for MATS2v descriptor is atomic
van der Waals volumes, which relate to the volume of the mol-
ecule. Thus increasing the volume of a molecule increases its
MATS2v value. Mean effect of Mor28v has the negative sign,
which indicates that an increase in the volume of molecule
leads to a decrease in its antimalarial activity.
HATS5e is one of the GETAWAY descriptors. The GET-
AWAY (GEometry, Topology, and Atom-Weights AssemblY)
descriptors have been recently proposed as chemical structure
descriptors derived from a new representation of molecular
structure, the Molecular Inﬂuence Matrix (MIM) (Consonni
et al., 2002). HATS4u is the leverage-weighted, autocorrelation
of lag 4/unweighted. The HATS5e mean effect has a positive
sign. This sign suggests that the antimalarial activity is directly
related to this descriptor.
M logP (Moriguchi octanol–water partition coefﬁcient)
(Moriguchi et al., 1992) is a popular and traditional descriptorused in QSAR model building. It describes one of the most
important properties of any compound- its lipophilicity, which
indicates the ability to penetrate lipid-rich zones from aqueous
solutions. Negative mean effect for this descriptor indicates
that an increase in the activity is observed with a decrease in
its lipophilicity.4. Conclusion
The aim of the present work was developing a QSAR study
and predicting the antimalaria activities of urea derivatives.
Various theoretical molecular descriptors were calculated by
DRAGON and CODESSA Software and selected by Genetic
Algorithm. The built GA–MLR model was assessed compre-
hensively (internal and external validations), and all the valida-
tions indicate that the QSAR model we built is robust and
satisfactory. Selection of eight variables showed that the XY
Shadow, HOMO-1 energy, reactivity of the atoms, minimum
net atomic charge on H atom, distance between the two oxy-
gen atoms, volume and lipophilicity of the molecule play a
main role in the antimalarial activity of the compounds.References
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